Assessing Levodopa Responses in Parkinsonian Disorders

This chapter explores the assessment of levodopa responses in patients with Parkinsonian disorders, emphasizing the need for baseline measurements and recognition of atypical symptoms. It provides insights into diagnostic challenges and frameworks to distinguish between idiopathic Parkinson's disease and atypical disorders such as PSP, CBD, and MSA.